» Articles » PMID: 14973384

The Preneoplastic Phenotype in Murine Mammary Tumorigenesis

Overview
Date 2004 Feb 20
PMID 14973384
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Preneoplastic lesions in murine mammary tumorigenesis have been extensively investigated over the past 50 years. The two general types of lesion that have malignant potential are the alveolar hyperplasias represented by the classical hyperplastic alveolar nodule and the ductal hyperplasias. The former type of lesion is induced by viral, chemical and hormonal agents; the latter by chemical agents and specific genetic alterations. Individual animal models have been utilized to elucidate the basic biological properties of the lesions and some of the basic molecular alterations. The biological phenotype of the two types of lesions include immortalization and epithelial hyperplasia. The ductal hyperplasias are distinguished from the alveolar hyperplasias by their pattern of epithelial hyperplasia and their extent of aneuploidy. The molecular alterations underlying epithelial hyperplasia are numerous and dependent on the particular animal model. An important issue for future studies is how faithfully any of these models mimic human premalignant progression. A minimal set of criteria is proposed that includes morphological progression, hormone dependence and genetic instability. It is likely that hyperplasias from a specific mouse model will represent a subset of the lesions found in human disease. Analogous hyperplasias from several defined genetic models, adequately characterized at the biological and molecular levels, would provide appropriate models for testing chemopreventive agents.

Citing Articles

A novel and cost-effective orthotopic model for the study of human breast cancer in mouse mammary gland organ culture.

Gupta A, Gupta G, Mehta R, Ivancic D, Walker R, Patel J Biol Open. 2020; 9(5).

PMID: 32366373 PMC: 7272353. DOI: 10.1242/bio.051649.


Modeling Human Ductal Carcinoma In Situ in the Mouse.

Behbod F, Gomes A, Machado H J Mammary Gland Biol Neoplasia. 2018; 23(4):269-278.

PMID: 30145750 PMC: 6244883. DOI: 10.1007/s10911-018-9408-0.


Mouse models for radiation-induced cancers.

Rivina L, Davoren M, Schiestl R Mutagenesis. 2016; 31(5):491-509.

PMID: 27209205 PMC: 6280996. DOI: 10.1093/mutage/gew019.


Scribble modulates the MAPK/Fra1 pathway to disrupt luminal and ductal integrity and suppress tumour formation in the mammary gland.

Godde N, Sheridan J, Smith L, Pearson H, Britt K, Galea R PLoS Genet. 2014; 10(5):e1004323.

PMID: 24852022 PMC: 4031063. DOI: 10.1371/journal.pgen.1004323.


Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors.

Soto A, Brisken C, Schaeberle C, Sonnenschein C J Mammary Gland Biol Neoplasia. 2013; 18(2):199-208.

PMID: 23702822 PMC: 3933259. DOI: 10.1007/s10911-013-9293-5.


References
1.
Lin T, Guzman R, OSBORN R, Thordarson G, Nandi S . Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice. Cancer Res. 1992; 52(16):4413-9. View

2.
Cardiff R, Moghanaki D, Jensen R . Genetically engineered mouse models of mammary intraepithelial neoplasia. J Mammary Gland Biol Neoplasia. 2004; 5(4):421-37. DOI: 10.1023/a:1009534129331. View

3.
Medina D, Warner M . Mammary tumorigenesis in chemical carcinogen-treated mice. IV. Induction of mammary ductal hyperplasias. J Natl Cancer Inst. 1976; 57(2):331-7. DOI: 10.1093/jnci/57.2.331. View

4.
Medina D, Kittrell F . Immortalization phenotype dissociated from the preneoplastic phenotype in mouse mammary epithelial outgrowths in vivo. Carcinogenesis. 1993; 14(1):25-8. DOI: 10.1093/carcin/14.1.25. View

5.
Coffey Jr R, Meise K, Matsui Y, Hogan B, Dempsey P, Halter S . Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene. Cancer Res. 1994; 54(7):1678-83. View